Insider Transactions in Q1 2023 at Cano Health, Inc. (CANO)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 31
2023
|
David J Armstrong |
BUY
Conversion of derivative security
|
Direct |
185,000
+18.02%
|
-
|
|
Mar 31
2023
|
Richard Aguilar Chief Clinical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
120,116
+10.89%
|
-
|
|
Mar 31
2023
|
David J Armstrong |
BUY
Grant, award, or other acquisition
|
Direct |
70,108
+11.3%
|
-
|
|
Mar 31
2023
|
Brian D Koppy Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
124,206
+13.07%
|
-
|
|
Mar 31
2023
|
Robert Camerlinck Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
70,486
+0.29%
|
-
|
|
Mar 31
2023
|
Marlow Hernandez |
BUY
Grant, award, or other acquisition
|
Direct |
348,604
+7.96%
|
-
|
|
Jan 05
2023
|
Brian D Koppy Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
28,528
-3.91%
|
$28,528
$1.08 P/Share
|
|
Jan 05
2023
|
Richard Aguilar Chief Clinical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
27,010
-3.04%
|
$27,010
$1.08 P/Share
|
|
Jan 05
2023
|
Mark Novell Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,538
-3.65%
|
$4,538
$1.08 P/Share
|
|
Jan 05
2023
|
David J Armstrong |
SELL
Payment of exercise price or tax liability
|
Direct |
19,749
-3.95%
|
$19,749
$1.08 P/Share
|
|
Jan 03
2023
|
Marlow Hernandez |
BUY
Grant, award, or other acquisition
|
Direct |
134,660
+3.53%
|
$0
$0.87 P/Share
|
|
Jan 03
2023
|
David J Armstrong |
BUY
Grant, award, or other acquisition
|
Direct |
13,006
+2.54%
|
$0
$0.87 P/Share
|